The Global Artificial Retina Implant Market is valued at approximately USD 1.31 billion in 2023 and is projected to grow with a healthy growth rate of over 20.96% over the forecast period 2024-2032.
Apellis Pharmaceuticals shares are moving lower after the Committee for Medicinal Products for Human Use of the European Medicines Agency confirmed its June 2024 negative opinion following ...
We are grateful to our new and returning investors who are making it possible for the company to achieve its vision of helping patients see the future,” commented David Esposito, chief executive ...
How Neurons Build a 3-D Vascular Structure to Keep the Retina Healthy May 24, 2024 — Scientists have known for years that a lattice of blood vessels nourishes cells in the retina that allow us ...
Their results, published in the journal Developmental Cell, offer promising insights for the future of photoreceptor replacement therapies. Vision is a complex sense that depends on the retina.
The following is a summary of “MicroRNA Regulation for Inflammasomes in High Glucose-Treated ARPE-19 Cells,” published in the August 2024 issue of Ophthalmology by Kim et al. Researchers conducted a ...
This CHMP opinion was made despite broad support for pegcetacoplan from the European retina community and multiple dissenting votes by CHMP members who supported a path to approval.” “We have seen the ...